L. Becker Hewes Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

L. Becker Hewes is Chief Medical Officer of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Oct 15, 2021, when has been sold 729 shares (Common Stock) at a price of $66.24 per share, resulting in proceeds of $48,289. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

L. Becker Hewes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 15 2021
BUY
Exercise of conversion of derivative security
$48,289 $66.24 p/Share
729 Added 2.64%
26,916 Common Stock
Sep 15 2021
SELL
Open market or private sale
$1,189,453 $100.52 p/Share
11,833 Reduced 31.12%
26,187 Common Stock
Sep 15 2021
BUY
Exercise of conversion of derivative security
$579,600 $66.24 p/Share
8,750 Added 18.71%
38,020 Common Stock
Jun 02 2021
SELL
Open market or private sale
$115,027 $89.03 p/Share
1,292 Reduced 4.23%
29,270 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
13,062 Added 29.94%
30,562 Common Stock
LBH

L. Becker Hewes

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC